Mutations of the GNAS1 gene, stromal cell dysfunction, and osteomalacic changes in non-McCune-Albright fibrous dysplasia of bone

Journal of Bone and Mineral Research

Volumn 15, Issue 1, 2000, Pages 120-128

  Bianco, P ^a   Riminucci, M ^a   Majolagbe, A ^b   Kuznetsov, S A ^b   Collins, M T ^b   Mankani, M H ^b   Corsi, A ^a   Bone, H G ^c   Wientroub, S ^d   Spiegel, A M ^e   Fisher, L W ^b   Gehron Robey, Pamela ^b  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c Michigan Bone and Mineral Clinic   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Animal model; Fibrous dysplasia; GNAS1; Gs ; McCune Albright syndrome; Mutation analysis; PNA; Transplantation

Indexed keywords

COMPLEMENTARY DNA;

ALBRIGHT SYNDROME; ARTICLE; FEMALE; FIBROUS DYSPLASIA; GENE SEQUENCE; HUMAN; HUMAN CELL; MALE; MOSAICISM; OSTEOMALACIA; SEQUENCE ANALYSIS; STROMA CELL;

EID: 0033971782     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2000.15.1.120     Document Type: Article

References (34)

1. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325:1688-1695.
2. Schwindinger WF, Francomano CA, Levine MA 1992 Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci USA 89:5152-5156.
3. Shenker A, Weinstein LS, Sweet DE, Spiegel AM 1994 An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 79:750-755.
4. Ringel MD, Schwindinger WF, Levine MA 1996 Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy. Medicine (Baltimore) 75:171-184.
5. Spiegel AM 1996 Defects in G protein-coupled signal transduction in human disease. Annu Rev Physiol 58:143-170.
6. Spiegel AM 1997 Inborn errors of signal transduction: Mutations in G proteins and G protein-coupled receptors as a cause of disease. J Inherit Metab Dis 20:113-121.
7. Spiegel AM 1997 The molecular basis of disorders caused by defects in G proteins. Horm Res 47:89-96.
8. Boothroyd CV, Grimmond SM, Cameron DP, Hayward NK 1995 G protein mutations in tumours of the pituitary, parathyroid, and endocrine pancreas. Biochem Biophys Res Commun 211:1063-1070.
9. Boston BA, Mandel S, LaFranchi S, Bliziotes M 1994 Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocnnol Metab 79:890-893.
10. Derwahl M 1996 Molecular aspects of the pathogenesis of nodular goiters, thyroid nodules and adenomas. Exp Clin Endocrinol Diabetes 104 Suppl 4:32-35.
11. Gorelov VN, Dumon K, Barteneva NS, Palm D, Roher HD, Goretzki PE 1995 Overexpression of Gs alpha subunit in thyroid tumors bearing a mutated Gs alpha gene. J Cancer Res Clin Oncol 121:219-224.
12. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F. 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655-659.
13. Huvos AG 1991 Bone Tumors: Diagnosis, Treatment and Prognosis. Saunders, New York, NY, U.S.A.
14. Alman BA, Greel DA, Wolfe HJ 1996 Activating mutations of Gs protein in monostotic fibrous lesions of bone. J Orthop Res 14:311-315.
15. Marie PJ, de Pollak C, Chanson P, Lomri A 1997 Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol 150:1059-1069.
16. Lichtenstein L, Jaffe HL 1942 Fibrous dysplasia of bone: A condition affecting one, several or many bones, the graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism, and still other extraskeletal abnormalities. Arch Pathol 33:777-797.
17. Jaffe HL 1958 Tumors and tumorous conditions of the bones and joints. Lea & Febiger, Philadelphia, PA, U.S.A.
18. Bianco P, Kuznetsov S, Riminucci M, Fisher LW, Spiegel AM, Gehron Robey P 1998 Reproduction of human fibrous dysplasia of bone in immunocompromised mice by transplanted mosaics of normal and Gs-alpha mutated skeletal progenitor cells. J Clin Invest 101:1737-1744.
19. Riminucci M, Liu B, Corsi A, Shenker A, Spiegel AM, Gehron Robey P, Bianco P 1999 The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks. J Pathol 187:249-258.
20. Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Riminucci M, Benayahu D, Robey PG 1997 Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 12:1335-1347.
21. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Gehron Robey P 1997 Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63:1059-1069.
22. Riminucci M, Fisher LW, Shenker A, Spiegel AM, Bianco P, Gehron Robey P 1997 Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol 151:1587-1600.
23. Boyde A, Maconnachie E, Reid SA, Celling G, Mundy GR 1986 Scanning electron microscopy in bone pathology: Review of methods, potential, and applications. Scan Electron Microsc Pt 4:1537-1554.
24. Spiegel AM 1996 Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 81:2434-2442.
25. Happle R 1986 The McCune-Albright syndrome: A lethal gene surviving by mosaicism. Clin Genetics 29:321-324.
26. Schwartz RA, Spicer MS, Leevy CB, Ticker JB, Lambert WC 1996 Cutaneous fibrous dysplasia: an incomplete form of the McCune-Albright syndrome. Dermatology 192:258-261.
27. Liens D, Delmas PD, Meunier PJ 1994 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 343:953-954.
28. Chapurlat RD, Delmas PD, Liens D, Meunier PJ 1997 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 12:1746-1752.
29. Candeliere GA, Roughley PJ, Glorieux FH 1997 Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone 21:201-206.
30. Park YK, Unni KK, Beabout JW, Hodgson SF 1994 Oncogenic osteomalacia: A clinicopathologic study of 17 bone lesions. J Korean Med Sci 9:289-298.
31. Dent CE, Gertner JM 1976 Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med 45:411-420.
32. Ryan WG, Nibbe AF, Schwartz TB, Ray RD 1968 Fibrous dysplasia of bone with vitamin D resistant rickets: a case study. Metabolism 17:988-998.
33. Kumar R 1997 Phosphatonin - a new phosphaturetic hormone? (Lessons from tumour-induced osteomalacia and X-linked hypophosphataemia) (Editorial). Nephrol Dial Transplant 12:11-13.
34. Zung A, Chalew SA, Schwindinger WF, Levine MA, Phillip M, Jara A, Counts DR, Kowarski AA 1995 Urinary cyclic adenosine 3′,5′-monophosphate response in McCune-Albright syndrome: Clinical evidence for altered renal adenylate cyclase activity. J Clin Endocrinol Metab 80:3576-3581.